Certara Appoints Patrick F. Smith to President of Integrated Drug DevelopmentGlobeNewsWire • 10/12/21
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission ProcessGlobeNewsWire • 09/30/21
Certara: Global Biosimulation Firm Positions Itself For Stability Into The Long TermSeeking Alpha • 09/29/21
Certara Announces New Clinical Science Group and Adds Senior Scientific ExpertsGlobeNewsWire • 09/22/21
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using BiosimulationGlobeNewsWire • 09/20/21
Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 09/13/21
Certara Inc's (CERT) CEO William Feehery on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21
Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 GuidanceBenzinga • 08/06/21
Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical DataGlobeNewsWire • 08/05/21
Certara's Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19GlobeNewsWire • 07/23/21
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board MembersGlobeNewsWire • 07/15/21
Certara Announces Update of BaseCase Software, the Company's Value Communication PlatformGlobeNewsWire • 07/08/21
Japan's Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara's Biosimulation Software for Evaluating Regulatory SubmissionsGlobeNewsWire • 06/23/21
Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare ConferenceGlobeNewsWire • 05/20/21
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology TherapiesGlobeNewsWire • 05/13/21